| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/22/1995 | EP0639374A2 New treatments using phenethyl derivatives |
| 02/22/1995 | EP0639224A1 Lectin domain variants of selectin |
| 02/22/1995 | EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 02/22/1995 | EP0639072A1 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration |
| 02/22/1995 | CN1099035A Spirocyclic piperidine derivatives |
| 02/22/1995 | CN1099033A Pyrazolo|4,3-c¨pyridines, a process for their preparation and their use as serotonin reuptake inhibitors |
| 02/22/1995 | CN1099032A Derivative of benzoxazine, preparation and pharmaceutical application of same |
| 02/22/1995 | CN1098907A Dry mix formulation for bisphosphonic acids |
| 02/22/1995 | CN1027695C Heterocyclic-NMDA antagonists |
| 02/22/1995 | CN1027694C Method for manufacturing of N-methyl-D-aspartic acid |
| 02/21/1995 | US5391775 Process for production of diacetylrhein |
| 02/21/1995 | US5391761 Preparation of novel amido-alcohol derivatives and their therapeutic uses |
| 02/21/1995 | US5391754 Oximination a tetrahydropyridin-3-aldehyde, alkylation with a halides, salt formation |
| 02/21/1995 | US5391742 2-(8-Azabicyclo(3.2.1)oct-8-yl)alkanols |
| 02/21/1995 | US5391577 N-phenylalkyl substituted α-amino carboxamide derivatives and process for their preparation |
| 02/21/1995 | US5391576 Method for treating and protecting the cerebral tissue against repercussions of cerebral ischaemia and cerebral infarctions |
| 02/21/1995 | US5391574 Antispasmodic agents |
| 02/21/1995 | US5391559 Antiischemic agents; antihypoxic agents; antiedemic agents |
| 02/21/1995 | US5391553 Increasing cholinergic functionin mammals |
| 02/21/1995 | US5391549 Cinnoline-3-carboxylic acid derivatives |
| 02/21/1995 | US5391375 Impermeable cover layer, pressure sensitive adhesive reservoir layer containing basic polymer, softener, physostigmine solution in acid solvent |
| 02/16/1995 | WO1995004752A1 Therapeutic peptide derivatives |
| 02/16/1995 | WO1995004734A1 Hydroisoquinoline derivatives |
| 02/16/1995 | WO1995004720A2 Gastrin and cck receptor ligands |
| 02/16/1995 | WO1995004713A1 2-aminoindans as selective dopamine d3 ligands |
| 02/16/1995 | WO1995004541A1 N-terminus modified analogs of lhrh |
| 02/16/1995 | WO1995004538A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 02/16/1995 | WO1995004536A1 Antiglucocorticoid steroids for the treatment of anxiety disorders |
| 02/16/1995 | WO1995004532A1 Substituted 2-aminotetralins |
| 02/16/1995 | WO1995004520A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection |
| 02/16/1995 | CA2168853A1 Hydroisoquinoline derivatives |
| 02/16/1995 | CA2167834A1 N-terminus modified analogs of lhrh |
| 02/16/1995 | CA2167154A1 Gastrin and cck receptor ligands |
| 02/16/1995 | CA2146547A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection |
| 02/16/1995 | CA2142349A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 02/15/1995 | EP0638569A1 Bicyclic nitrogenous compound |
| 02/15/1995 | EP0638554A1 Process for producing a N-phenyl-N-(4-piperidinyl) amide derivative |
| 02/15/1995 | EP0638081A1 Delta opioid receptor-selective benzylidene-substituted morphinans for the treatment of alcohol abuse |
| 02/15/1995 | EP0638073A1 1-piperazino-1,2-dihydroindene derivatives |
| 02/15/1995 | EP0637956A1 Use of remacemide for the treatment of parkinson's disease |
| 02/15/1995 | EP0394484B1 Benzothiadiazepine derivatives |
| 02/14/1995 | US5389684 Naphthalene carboxamides |
| 02/14/1995 | US5389683 Useful in treating or preventing a disorder of the melatoninergic system |
| 02/14/1995 | US5389681 Parenteral solutions for diclofenac salts |
| 02/14/1995 | US5389670 Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder |
| 02/14/1995 | US5389668 Thiochroman compounds |
| 02/14/1995 | US5389643 Aminobenzoic acid derivatives useful for treating gastro-intestinal conditions |
| 02/14/1995 | US5389630 Diamine compound and brain protecting agent containing the same |
| 02/14/1995 | CA1334416C 4-phenyl-4-¬n-(phenyl)amido|piperidine derivatives and pharmaceutical compositions and method employing such compounds |
| 02/14/1995 | CA1334382C Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having improved core membrane adhesion properties |
| 02/09/1995 | WO1995004056A1 Heterocyclic amines having central nervous system activity |
| 02/09/1995 | WO1995004051A1 Piperazine compounds used in therapy |
| 02/09/1995 | WO1995004049A1 PIPERAZINE DERIVATIVES AS α1A-ADRENERGIC RECEPTOR ANTAGONISTS |
| 02/09/1995 | WO1995004047A1 2-benzoheterocyclyloxy or thiopropanolamine derivatives with adreno receptor agonist activity |
| 02/09/1995 | WO1995004045A1 Compounds as pde iv and tnf inhibitors |
| 02/09/1995 | WO1995004042A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists |
| 02/09/1995 | WO1995004039A1 2-phenylpyrrole derivatives as dopamine d3 receptor antagonists |
| 02/09/1995 | WO1995004037A1 2-(2-hydroxyphenyl)-5-(n-phenylmethyl-aminomethyl)-pyrroles as antipsychotic agents |
| 02/09/1995 | WO1995004028A1 Indane and tetrahydronaphthalene derivatives as calcium channel antagonists |
| 02/09/1995 | WO1995004027A1 Aminoindanes and related compounds useful as calcium-channel antagonists |
| 02/09/1995 | WO1995003827A1 Method for treating multiple sclerosis |
| 02/09/1995 | WO1995003821A1 Prosaposin and cytokine-derived peptides as therapeutic agents |
| 02/09/1995 | WO1995003804A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict |
| 02/09/1995 | WO1995003791A1 Stabilized pharmaceutical composition containing bupropion |
| 02/09/1995 | WO1995003753A1 Medicinal for protection from neurological damage |
| 02/09/1995 | WO1994022437A3 Method for treating amyloidosis |
| 02/09/1995 | CA2168443A1 Piperazine derivatives as .alpha.1a-adrenergic receptor antagonists |
| 02/09/1995 | CA2168262A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict |
| 02/09/1995 | CA2168257A1 Aminoindanes and related compounds useful as calcium-channel antagonists |
| 02/09/1995 | CA2167411A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists |
| 02/08/1995 | EP0637586A1 2-(Piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl)benzofuran-7-ol and carbamate derivatives, their preparation and their use as acetylcholinesterase inhibitors |
| 02/08/1995 | EP0637315A1 Adenosine derivatives having a 2? agonist activity |
| 02/08/1995 | EP0637308A1 Benzodiazepine derivatives, compositions containing them and their use in therapy |
| 02/08/1995 | EP0637307A1 Imidazole, triazole and tetrazole derivatives |
| 02/08/1995 | EP0637306A1 4-imidomethyl-1- 2'phenyl-2'oxoethyl-] piperidines as serotonin 5ht 2?-antagonists, their preparation and use in therapy |
| 02/08/1995 | EP0637242A1 Agents for treating substance abuse disorders |
| 02/08/1995 | EP0637203A1 Regulation of the immune system |
| 02/08/1995 | CN1098414A Novel triazolopyrimidones, their preparation and use |
| 02/08/1995 | CN1098297A Intelligence-increasing health-care medicinal core and its preparation method |
| 02/08/1995 | CN1027588C Process for the preparation of N-phenylalkyl substituted alpha-amino carboxamide derivatives |
| 02/07/1995 | US5387710 Ethanolamine derivatives having sympathomimetic and anti-pollakiuria activities |
| 02/07/1995 | US5387615 L-deprenyl for treating immune system dysfunction and compositions for same |
| 02/07/1995 | US5387612 Administering title compound or salt; memory disorders |
| 02/07/1995 | US5387604 Useful in treatment of anxiety, depression, migraine, stroke and hypertension |
| 02/07/1995 | US5387600 Treating arteriosclerosis using benzimidazole compositions |
| 02/07/1995 | US5387593 Anxiolytic agents |
| 02/07/1995 | US5387590 Analgesics |
| 02/07/1995 | US5387586 (Aryl(alkyl)carbonyl)-heterocyclic compounds, compositions and use |
| 02/07/1995 | US5387585 Treating epilepsy, anxiety, sleep disorders, schizophrnia, senile dementia |
| 02/07/1995 | CA2028514C Treatment of depression |
| 02/06/1995 | CA2129462A1 2-(piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl)benzofuran-7-ol and carbamate derivatives |
| 02/04/1995 | CA2129301A1 Benzo-fused heterocyclic compounds with a 5-membered ring, process for their preparation, their use as medicaments, their use as diagnostic agents, and medicaments containing them |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003313A1 Novel silylated benzylamine derivatives, salts thereof, methods of manufacture and pharmaceutical compositions containing them |
| 02/02/1995 | WO1995003304A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/02/1995 | WO1995003303A2 Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| 02/02/1995 | WO1995003298A1 BENZIMIDAZOLE DERIVATIVES USEFUL AS DOPAMINE RECEPTOR ANTAGONIST, 5-HT RECEPTOR AGONIST OR α1 RECEPTOR ANTAGONIST |
| 02/02/1995 | WO1995003295A1 Endothelin antagonists |
| 02/02/1995 | WO1995003285A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |